In hepatocellular carcinoma, lnc-CTHCC, stabilized by METTL3/IGF2BP1/IGF2BP3 via m6A modification, promotes tumor initiation and development by binding hnRNPK and activating YAP1 transcription [58]. The gene discussed is IGF2BP3; the disease is neoplasm.